FDA NDC Directory · JSON-LD · Markdown

Liraglutide

NDC 70377-094 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameliraglutide
Labeler / ManufacturerBiocon Pharma Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215245
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsLIRAGLUTIDE (6 mg/mL)
Marketing started20260425
Package count2

External sources

Source: openFDA. Public-domain (CC0).